Financhill
Back

Immunovant Stock Predictions

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 104.4% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $29.17. The Score for IMVT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 104.4% based on the past 5 years of stock performance.

Immunovant Stock Rating

Buy
54
Immunovant (IMVT) is a Buy

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
24.67

Prediction Charts

Market Cap:
4.27B
Price in USD:
29.17
Volume:
2.08M
Beta:
0.71

Technical Analysis

SMA50:
29.99
SMA100:
28.77
SMA200:
31.30
52-Wk Change:
-22.73%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 29.17 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-27 28.60 28.02 28.88 27.77
Sep-30 27.65 28.50 28.75 27.61
Oct-1 28.37 28.44 28.79 28.05
Oct-2 28.37 29.52 29.65 28.05
Oct-3 29.33 29.30 29.48 28.74
Oct-4 29.73 30.51 30.66 29.53
Oct-7 30.41 29.42 30.58 28.92
Oct-8 29.33 29.61 29.69 29.07
Oct-9 29.74 30.03 30.08 29.24
Oct-10 30.42 29.93 30.49 29.67
Oct-11 29.86 30.40 30.63 29.67
Oct-14 30.45 29.44 30.50 29.37
Oct-15 29.31 28.55 29.49 28.53
Oct-16 28.52 29.17 29.31 28.25

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.66 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.